Kingchem(301509.SZ)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
Kingchem
301509.SZ
Kingchem (Liaoning) Life Science Co., Ltd. engages in the provision of small molecule CDMO services for life science customers in China and internationally. The company offers fluorine-containing products, such as trifluoromethoxy or trifluoromethyl benzene intermediates, and fluorinated aromatic ring intermediates. It also provides non-fluorinated products, including nitrogen-containing heterocyclic series, aliphatic organic derivatives of ammonia, carboxylic acids and their derivatives, olefins, nonfluorinated halogenated benzenes, phenols, ketones, and isocyanates.
3.085 T
301509.SZMarket value -Rank by Market Cap -/-

Financial Score

27/01/2026 Update
B
PharmaceuticalsIndustry
Industry Ranking63/222
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE4.73%C
    • Profit Margin17.20%A
    • Gross Margin59.29%A
  • Growth ScoreC
    • Revenue YoY5.21%C
    • Net Profit YoY54.14%B
    • Total Assets YoY1.61%C
    • Net Assets YoY2.81%C
  • Cash ScoreC
    • Cash Flow Margin581.55%C
    • OCF YoY5.21%C
  • Operating ScoreD
    • Turnover0.26D
  • Debt ScoreA
    • Gearing Ratio5.22%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Kingchem: The net profit for the third quarter was 31.6687 million yuan, a year-on-year increase of 339.92%

    Kingchem announced that its revenue for the third quarter was 139 million yuan, a year-on-year increase of 11.27%; net profit was 31.6687 million yuan, a year-on-year increase of 339.92%. Revenue for the first three quarters was 488 million yuan, a year-on-year increase of 25.96%; net profit was 103 million yuan, a year-on-year increase of 163.24%

    Zhitong·
    SZ
    301509
    +0.37%
    Zhitong·
    SZ
    301509
    +0.37%

    Kingchem released its performance for the first half of the year, with a net profit attributable to the parent company of 71.7606 million yuan, an increase of 123.61%

    Kingchem released its semi-annual report for 2025, with operating revenue of 348 million yuan, a year-on-year increase of 32.98%. The net profit attributable to the parent company was 71.7606 million yuan, an increase of 123.61%; the net profit after deducting non-recurring gains and losses was 59.1748 million yuan, an increase of 141.51%. The basic earnings per share were 0.6 yuan

    Zhitong·
    SZ
    301509
    +0.37%
    Zhitong·
    SZ
    301509
    +0.37%

    Kingchem: The company's existing products and business do not involve the field of PEEK materials

    On August 11th, Kingchem responded on the interactive platform that the company is currently focused on small molecule CDMO services in the life sciences field, and its existing products and business do not involve the PEEK materials sector

    Zhitong·
    SZ
    301509
    +0.37%
    Zhitong·
    SZ
    301509
    +0.37%

    The medical services sector has seen a short-term decline, with Kingchem falling over 8%

    The medical services sector has seen a short-term decline, with Kingchem dropping over 8%, followed by PR, Bio-S, HitGen, and AHWB

    Zhitong·
    SZ
    301096
    -1.91%
    SH
    688222
    +1.55%
    SZ
    301520
    +0.09%
    Zhitong·
    SZ
    301096
    -1.91%
    SH
    688222
    +1.55%
    SZ
    301520
    +0.09%

    Kingchem: Qilu Investment and Qingsong Investment plan to reduce their holdings by 3% and 1% respectively

    Kingchem announced that its shareholder Qilu Investment plans to reduce its holdings by no more than 3.612 million shares, accounting for 3% of the company's total share capital. Among them, no more than 1.204 million shares will be reduced through centralized bidding, accounting for 1% of the company's total share capital; no more than 2.408 million shares will be reduced through block trading, accounting for 2% of the company's total share capital. Shareholder Qingsong Investment plans to reduce its holdings by no more than 1.204 million shares through centralized bidding, accounting for 1% of the company's total share capital. The reduction period is within three months after fifteen trading days from the date of the announcement

    Zhitong·
    SZ
    301509
    +0.37%
    Zhitong·
    SZ
    301509
    +0.37%
    © 2026 Longbridge｜Disclaimer